Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_assertion type Assertion NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_head.
- NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_assertion description "[Using quantitative ELISA immunoassay we found that the CSF levels of Vgf decreases with muscle weakness in patients with ALS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_provenance.
- NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_assertion evidence source_evidence_literature NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_provenance.
- NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_assertion SIO_000772 18432310 NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_provenance.
- NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_assertion wasDerivedFrom befree-20140225 NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_provenance.
- NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_assertion wasGeneratedBy ECO_0000203 NP675019.RAGpZ3-OfoQniHodrJMdGbC3VHY3A3JcFlQ88JBcAsqL8130_provenance.